$Alzamend Neuro(ALZN.US)$10% Shareholder AULT MILTON C III purchased 700 shares of Common Stocks on Dec 22, 26, 2023 at an average price of $0.9069 for a total value of $634.84.
$Alzamend Neuro(ALZN.US)$Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients
benji Cohan :
Srav Reddy : 非常感謝您在這些生物科技事務上的幫助。如果您也可以支付 $XFOR,感謝您。